Piper Sandler Reaffirms “Overweight” Rating for Altimmune (NASDAQ:ALT)
Piper Sandler reaffirmed their overweight rating on shares of Altimmune (NASDAQ:ALT – Free Report) in a research note released on Friday morning, Benzinga reports. Piper Sandler currently has a $25.00 price target on the stock. A number of other brokerages have also recently commented on ALT. HC Wainwright reaffirmed a buy rating and set a […]
More Stories
QUALCOMM Incorporated (NASDAQ:QCOM) Given Consensus Recommendation of “Moderate Buy” by Brokerages
QUALCOMM Incorporated (NASDAQ:QCOM – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the twenty-six ratings...
PepsiCo, Inc. (NASDAQ:PEP) Receives $185.53 Consensus Price Target from Brokerages
PepsiCo, Inc. (NASDAQ:PEP – Get Free Report) has been assigned an average recommendation of “Hold” from the fourteen brokerages that...
PayPal Holdings, Inc. (NASDAQ:PYPL) Given Average Recommendation of “Moderate Buy” by Brokerages
Shares of PayPal Holdings, Inc. (NASDAQ:PYPL – Get Free Report) have received a consensus rating of “Moderate Buy” from the...
Short Interest in Ohio Valley Banc Corp. (NASDAQ:OVBC) Grows By 25.5%
Ohio Valley Banc Corp. (NASDAQ:OVBC – Get Free Report) saw a significant increase in short interest in the month of...
Collective effort essential to get DR Congo on firm path to peace
Mobilization at the national, regional and international level are needed to support the Democratic Republic of the Congo (DRC) in...
Short Interest in Tredegar Co. (NYSE:TG) Grows By 17.1%
Tredegar Co. (NYSE:TG – Get Free Report) saw a large growth in short interest during the month of September. As...